- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2012
- Public Summary Document (PSD) July 2012 PBAC Meeting - PDF
Dabigatran etexilate – July 2012
Dabigatran etexilate, capsules, 110 mg and 150 mg (as mesilate), Pradaxa®
Last updated
8 November 2023